Nosopharm nosopharm.com


Public lists: Pharma Startups (4732)

Nosopharm is a biotechnology company specialized in the research and development of new antimicrobial molecules. The company discovered and developed NOSO-95179, an antibiotic for the treatment of multidrug-resistant hospital-acquired infections. Nosopharm has developed an expertise in the discovery of natural bioactive products stemming from the Xenorhadbus and Photorhabdus microbial genus and in the medicinal chemistry of Odilorhabdin, the new class of antibiotics to which NOSO-95179 belongs.

Nosopharm is a biotechnology company specialized in the research and development of new antimicrobial molecules. The company discovered and developed NOSO-95179, an antibiotic for the treatment of multidrug-resistant hospital-acquired infections. Nos...Show all

Company (Alive / Active)

Phone: +33 (0) 411 716 185

Fax:

Danica B
21 avenue Georges Pompidou
Lyon, 69486
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Nosopharm $5M Feb 12, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Nosopharm Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
AurigaVenture CapitalParis, FranceSeed VC
Alto InvestPrivate EquityVersailles, FranceSeed VC
BPI FranceDiversified Financial ServicesMaisons-Alfort, FranceLoan
Ministere de la DefenseGovernmentFranceGrant
KreaxiVenture CapitalParis, FranceSeed VC
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Process for preparing 2,4-diamino-3-hydroxybutyric acid derivatives Mar 02, 2015 Aug 15, 2017 Patent
Peptide derivatives as antibiotics Sep 28, 2012 Feb 16, 2016 Patent
Peptide derivatives and uses thereof Sep 25, 2015 Application